3Helix

3Helix 3Helix develops a novel collagen targeting technology, providing scientists and clinicians with new tools to study and diagnose collagen pathologies.

3Helix develops and markets a novel collagen targeting technology, providing scientists and clinicians with new tools to investigate collagen pathology and to develop diagnostics and therapeutics for diseases with high collagen remodeling activities.

10/09/2017

The 2017 Translational Medicine Symposium was held on Feb. 27th. The symposium addressed how clinicians’ ideas and research results can have an impact on pat...

Studies enabled by our Collagen Hybridizing Peptides (CHP):
10/09/2017

Studies enabled by our Collagen Hybridizing Peptides (CHP):

Collagen denaturation is thought to occur during tissue mechanical damage, but its role in damage initiation is still unclear. Here, the authors use a collagen hybridizing peptide to provide insights into the molecular mechanisms leading to collagen unfolding during tendo…

03/24/2016

Salt Lake City, Utah, Match 24, 2016 Biotechnology company 3Helix, Inc. ("3Helix") announced today that it has received a $150,000 Phase I Small Busi

Address

Salt Lake City, UT
84108

Opening Hours

Monday 9am - 5pm
Tuesday 9am - 5pm
Wednesday 9am - 5pm
Thursday 9am - 5pm
Friday 9am - 5pm

Telephone

(385) 722-4772

Website

Alerts

Be the first to know and let us send you an email when 3Helix posts news and promotions. Your email address will not be used for any other purpose, and you can unsubscribe at any time.

Contact The Business

Send a message to 3Helix:

Shortcuts

Share

Category